Understanding how healthcare access affects lung cancer outcomes among different racial groups
Healthcare Access Dimensions and Racial Disparities in Lung Cancer
['FUNDING_R01'] · WASHINGTON UNIVERSITY · NIH-10839821
This study is looking at how different racial and ethnic groups, especially African Americans and European Americans, experience lung cancer treatment differently, and it wants to find out what factors make it harder for some people to get the care they need, so we can help improve outcomes for everyone.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-10839821 on ClinicalTrials.gov |
What this research studies
This research investigates the disparities in lung cancer treatment and outcomes among different racial and ethnic groups, particularly focusing on non-Hispanic African Americans and non-Hispanic European Americans. It aims to identify modifiable factors that influence access to lung cancer care, beyond just insurance coverage and provider availability. By examining dimensions of healthcare access such as affordability, accommodation, acceptability, availability, and accessibility, the study seeks to uncover barriers that contribute to poorer outcomes in certain populations. The findings could lead to targeted strategies to improve care and outcomes for underrepresented groups.
Who could benefit from this research
Good fit: Ideal candidates for this research include non-Hispanic African American patients diagnosed with lung cancer who may face barriers to accessing care.
Not a fit: Patients who are not diagnosed with lung cancer or who do not belong to the racial/ethnic groups being studied may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved lung cancer treatment access and outcomes for racial and ethnic minorities.
How similar studies have performed: Previous research has shown that addressing modifiable barriers to healthcare access can improve treatment outcomes, suggesting that this approach may be effective.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIU, YING — WASHINGTON UNIVERSITY
- Study coordinator: LIU, YING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: NSCLC - Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Disorder, Disease